TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Prevalence of Autism Spectrum Disorder for Key Countries/Region 4.2. Recent Industry Developments Such As Partnerships, Mergers, & Acquisitions 4.3. Regulatory Framework by Key Countries 4.4. Global Reimbursement Scenario and Economic Cost Burden for the Treatment of Autism Spectrum Disorder by Key Countries/Region 5. Global Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Type 5.2.1. Autistic Disorder 5.2.2. Asperger Syndrome 5.2.3. Pervasive Developmental Disorder 5.2.4. Others 5.3. Market Analysis, Insights and Forecast – By Treatment Type 5.3.1. Communication & Behavioral Therapies 5.3.1.1. Applied behavior analysis (ABA) 5.3.1.2. Speech & Language Therapy 5.3.1.3. Occupational Therapy 5.3.1.4. Others 5.3.2. Drug Therapies 5.3.2.1. Antipsychotic Drugs 5.3.2.2. SSRIS 5.3.2.3. Stimulants 5.3.2.4. Sleep Medications 5.3.2.5. Others 5.4. Market Analysis, Insights and Forecast – By Region 5.4.1. North America 5.4.2. Europe 5.4.3. Asia pacific 5.4.4. Latin America 5.4.5. Middle East & Africa 6. North America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis – By Type 6.2.1. Autistic Disorder 6.2.2. Asperger Syndrome 6.2.3. Pervasive Developmental Disorder 6.2.4. Others 6.3. Market Analysis – By Treatment Type 6.3.1. Communication & Behavioral Therapies 6.3.1.1. Applied behavior analysis (ABA) 6.3.1.2. Speech & Language Therapy 6.3.1.3. Occupational Therapy 6.3.1.4. Others 6.3.2. Drug Therapies 6.3.2.1. Antipsychotic Drugs 6.3.2.2. SSRIS 6.3.2.3. Stimulants 6.3.2.4. Sleep Medications 6.3.2.5. Others 6.4. Market Analysis – By Country 6.4.1. U.S. 6.4.2. Canada 7. Europe Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis – By Type 7.2.1. Autistic Disorder 7.2.2. Asperger Syndrome 7.2.3. Pervasive Developmental Disorder 7.2.4. Others 7.3. Market Analysis – By Treatment Type 7.3.1. Communication & Behavioral Therapies 7.3.1.1. Applied behavior analysis (ABA) 7.3.1.2. Speech & Language Therapy 7.3.1.3. Occupational Therapy 7.3.1.4. Others 7.3.2. Drug Therapies 7.3.2.1. Antipsychotic Drugs 7.3.2.2. SSRIS 7.3.2.3. Stimulants 7.3.2.4. Sleep Medications 7.3.2.5. Others 7.4. Market Analysis – By Country/Sub-region 7.4.1. U.K. 7.4.2. Germany 7.4.3. France 7.4.4. Spain 7.4.5. Italy 7.4.6. Scandinavia 7.4.7. Rest of Europe 8. Asia Pacific Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis – By Type 8.2.1. Autistic Disorder 8.2.2. Asperger Syndrome 8.2.3. Pervasive Developmental Disorder 8.2.4. Others 8.3. Market Analysis – By Treatment Type 8.3.1. Communication & Behavioral Therapies 8.3.1.1. Applied behavior analysis (ABA) 8.3.1.2. Speech & Language Therapy 8.3.1.3. Occupational Therapy 8.3.1.4. Others 8.3.2. Drug Therapies 8.3.3. Antipsychotic Drugs 8.3.3.1. SSRIS 8.3.3.2. Stimulants 8.3.3.3. Sleep Medications 8.3.3.4. Others 8.4. Market Analysis – By Country/Sub-region 8.4.1. Japan 8.4.2. China 8.4.3. India 8.4.4. Australia 8.4.5. Southeast Asia 8.4.6. Rest of Asia Pacific 9. Latin America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis – By Type 9.2.1. Autistic Disorder 9.2.2. Asperger Syndrome 9.2.3. Pervasive Developmental Disorder 9.2.4. Others 9.3. Market Analysis – By Treatment Type 9.3.1. Communication & Behavioral Therapies 9.3.1.1. Applied behavior analysis (ABA) 9.3.1.2. Speech & Language Therapy 9.3.1.3. Occupational Therapy 9.3.1.4. Others 9.3.2. Drug Therapies 9.3.2.1. Antipsychotic Drugs 9.3.2.2. SSRIS 9.3.2.3. Stimulants 9.3.2.4. Sleep Medications 9.3.2.5. Others 9.4. Market Analysis – By Country/Sub-region 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 10. Middle East & Africa Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis – By Type 10.2.1. Autistic Disorder 10.2.2. Asperger Syndrome 10.2.3. Pervasive Developmental Disorder 10.2.4. Others 10.3. Market Analysis – By Treatment Type 10.3.1. Communication & Behavioral Therapies 10.3.1.1. Applied behavior analysis (ABA) 10.3.1.2. Speech & Language Therapy 10.3.1.3. Occupational Therapy 10.3.1.4. Others 10.3.2. Drug Therapies 10.3.2.1. Antipsychotic Drugs 10.3.2.2. SSRIS 10.3.2.3. Stimulants 10.3.2.4. Sleep Medications 10.3.2.5. Others 10.4. Market Analysis – By Country/Sub-region 10.4.1. GCC Countries 10.4.2. South Africa 10.4.3. Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability)) 11.5.1. Allergan 11.5.2. Q BioMed Inc 11.5.3. Hopebridge, LLC. 11.5.4. Center for Autism and Related Disorders 11.5.5. Behavior Innovations 11.5.6. Applied Behavior Consultants 11.5.7. Fusion Autism Center 11.5.8. Otsuka Holdings Co. Ltd. 11.5.9. AstraZeneca 11.5.10. Pfizer Inc. 11.5.11. Eli Lilly and Company 11.5.12. Johnson & Johnson Services, Inc.

Allergan Q BioMed Inc Hopebridge, LLC. Center for Autism and Related Disorders. Behavior Innovations Applied Behavior Consultants Fusion Autism Center Otsuka Holdings Co. Ltd. AstraZeneca Pfizer Inc. Eli Lilly and Company. Johnson & Johnson Services, Inc.